Subclinical vasculitis as a potential mechanism to explain the heightened cardiovascular risk in rheumatoid arthritis
- PMID: 23095281
- PMCID: PMC4062357
- DOI: 10.1161/CIRCULATIONAHA.112.146092
Subclinical vasculitis as a potential mechanism to explain the heightened cardiovascular risk in rheumatoid arthritis
Conflict of interest statement
Comment on
-
Anti-tumor necrosis factor-α therapy reduces aortic inflammation and stiffness in patients with rheumatoid arthritis.Circulation. 2012 Nov 20;126(21):2473-80. doi: 10.1161/CIRCULATIONAHA.112.120410. Epub 2012 Oct 24. Circulation. 2012. PMID: 23095282 Clinical Trial.
References
-
- Rudd JH, Warburton EA, Fryer TD, Jones HA, Clark JC, Antoun N, Johnström P, Davenport AP, Kirkpatrick PJ, Arch BN, Pickard JD, Weissberg PL. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation. 2002;105:2708–2711. - PubMed
-
- Yun M, Yeh D, Araujo LI, Jang S, Newberg A, Alavi A. F-18 FDG uptake in the large arteries: a new observation. Clin Nucl Med. 2001;26:314–319. - PubMed
-
- Bucerius J, Duivenvoorden R, Mani V, Moncrieff C, Rudd JH, Calcagno C, Machac J, Fuster V, Farkouh ME, Fayad ZA. Prevalence and risk factors of carotid vessel wall inflammation in coronary artery disease patients: FDG-PET and CT imaging study. JACC Cardiovasc Imaging. 2011;4:1195–1205. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical